Enhancing cardiovascular imaging department efficiency through robust quality systems and effective risk management
Roberta Lo Giudice, Alessia Gimelli, Marianna Venditti

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCardiac Imaging and Diagnostics · Radiation Dose and Imaging · Advanced X-ray and CT Imaging
Introduction
The cardiovascular imaging landscape has witnessed remarkable advancements, allowing for more precise diagnoses and targeted treatments. One crucial aspect contributing to the success of cardiovascular imaging is the implementation of a robust quality system and effective risk management. To support this concept, this e-letter delves into the findings of a recent study assessing the appropriateness of referrals to a nuclear cardiology laboratory for stress myocardial perfusion imaging (MPI) and highlights the profound impact of a healthy quality system on patient outcomes and resource utilization.^1^
The study evaluated 1870 consecutive patients undergoing MPI. The assessment considered the appropriateness of imaging test referrals based on the 2023 Appropriate Use Criteria and the European Society of Cardiology (ESC) guidelines for chronic coronary syndromes.^2^ Notably, 88% of MPI tests were classified as ‘appropriate’, reinforcing the importance of adherence to established criteria in clinical decision-making. Moreover, appropriate referrals were associated with a higher incidence of moderate-to-severe ischaemia, highlighting the diagnostic accuracy and efficacy of the MPI in cases where the test was deemed appropriate. In contrast, inappropriate and uncertain referrals demonstrated lower rates of ischaemia, emphasizing the importance of proper test indications in obtaining meaningful results. The adoption of ESC guidelines further strengthened the case for quality in the referral process.^2^ Patients managed by guidelines showed a significantly higher prevalence of obstructive coronary artery disease during invasive coronary angiography. This aligns with the broader concept that appropriateness in test referrals leads to better downstream resource utilization, promoting optimal patient care.^3^
Risk management and patient outcomes
A well-structured quality system not only ensures appropriateness in test referrals but also plays a pivotal role in risk management. The study indicates that adherent management to the international guidelines, which should ideally be linked to the most advanced clinical and pharmacological trials, resulted in a higher likelihood of coronary revascularization compared with non-adherent cases. This implies that when clinical decisions are guided by established protocols grounded in the latest research, the chances of identifying and addressing significant cardiovascular issues are significantly improved, as demonstrated by the EURECA registry.^4^
The importance of continuous quality improvement
The findings underscore the need for continuous quality improvement in cardiovascular imaging departments, emphasizing the crucial role of the established health quality system and the imperative to adhere diligently to standard operating procedures. Regular evaluations of appropriateness criteria and guideline adherence can identify areas for enhancement, contributing to the evolution of best practices. Furthermore, ongoing training and education for healthcare professionals involved in the referral process are essential to maintaining a high standard of care. Finally, a key aspect of quality improvement is the emphasis on data collection and analysis in each cardiac imaging department. By leveraging data, cardiac imaging departments can identify trends, measure performance metrics, and implement targeted improvements. This data-driven approach empowers healthcare providers to make informed decisions, fostering a culture of continuous learning and improvement.
Resource optimization and cost-efficiency
Beyond the immediate impact on patient outcomes, a healthy quality system and effective risk management contribute to resource optimization and cost-efficiency. Appropriate test referrals minimize unnecessary procedures, reducing the strain on healthcare resources and mitigating financial burdens on both patients and healthcare systems. In contrast, inappropriate referrals can lead to unnecessary tests and procedures, adding to the overall healthcare expenditure without commensurate benefits.
Conclusion
The study on the appropriateness of referrals to a nuclear cardiology laboratory sheds light on the far-reaching implications of a well-established quality system and effective risk management in cardiovascular imaging departments.^1^ The high rate of appropriate MPI tests is not only indicative of the current state of quality in clinical decision-making but also emphasizes the potential for continuous improvement.
As we navigate the evolving landscape of healthcare, it is imperative to recognize the pivotal role that quality systems and risk management play in shaping patient outcomes, resource utilization, and the overall efficiency of cardiovascular imaging departments. Embracing a culture of continuous improvement ensures that these departments remain at the forefront of delivering high-quality, patient-centred care.
Conflict of interest: R.L.G., A.G., and M.V. have nothing to disclose.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Liga R, Grassini D, Giorgetti A, Grasso E, Dalmiani S, Gimelli A. Impact of appropriateness in clinical practice: data from a single-centre nuclear cardiology laboratory. Eur Heart J Imaging Methods Pract 2023;1:qyad 036.
- 2Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C et al 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407–77.31504439 10.1093/eurheartj/ehz 425 · doi ↗ · pubmed ↗
- 3Kumar A, Patel DR, Harb SC, Greenberg NL, Bhargava A, Menon V et al Implementation of a myocardial perfusion imaging risk algorithm to inform appropriate downstream invasive testing and treatment. Circ Cardiovasc Imaging 2021;14:e 011984.33765835 10.1161/CIRCIMAGING.120.011984 · doi ↗ · pubmed ↗
- 4Neglia D, Liga R, Gimelli A, Podlesnikar T, Cvijić M, Pontone G et al Use of cardiac imaging in chronic coronary syndromes: the EURECA imaging registry. Eur Heart J 2023;44:142–58.36452988 10.1093/eurheartj/ehac 640 · doi ↗ · pubmed ↗
